Kamada (KMDA) Total Current Liabilities (2012 - 2026)
Kamada's (KMDA) quarterly Total Current Liabilities came in at $59.8 million in Q1 2026, up 4.78% YoY from $57.0 million in Q1 2025, and up 26.13% on a QoQ basis from $47.4 million in Q4 2025.
Kamada (KMDA) Total Current Liabilities (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 13 years of Total Current Liabilities data on file, last reported at $59.8 million in Q1 2026.
- Quarterly Total Current Liabilities rose 4.78% year-over-year to $59.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.8 million (up 4.78% YoY) and the FY2025 annual result came in at $47.4 million, down 4.04% from the prior year.
- Total Current Liabilities rose to $59.8 million in Q1 2026, from $47.4 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $75.7 million in Q4 2022 to a low of $69150.0 in Q3 2022.
- A 5-year average of $43.5 million and a median of $47.4 million in 2025 frame the typical range for Total Current Liabilities.
- The widest YoY moves for Total Current Liabilities: up 53800.22% in 2023, down 99.84% in 2023.
- Tracing KMDA's Total Current Liabilities over 5 years: stood at $75.7 million in 2022, then tumbled by 34.49% to $49.6 million in 2023, then fell by 0.41% to $49.4 million in 2024, then declined by 4.04% to $47.4 million in 2025, then climbed by 26.13% to $59.8 million in 2026.
- The last three Total Current Liabilities figures came in at $59.8 million (Q1 2026), $47.4 million (Q4 2025), and $47.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.79 Bn |
| 10 | Kamada | 465.49 Mn | 436.02 Mn | 22.47 Mn | 49.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 49.16 Mn |
| Mar 31, 2026 | 59.78 Mn |
| Dec 31, 2025 | 47.39 Mn |
| Sep 30, 2025 | 47.84 Mn |
| Jun 30, 2025 | 45.77 Mn |
| Mar 31, 2025 | 57.05 Mn |
| Dec 31, 2024 | 49.39 Mn |
| Sep 30, 2024 | 34.00 Mn |
| Jun 30, 2024 | 40.90 Mn |
| Mar 31, 2024 | 37.18 Mn |
| Dec 31, 2023 | 49.59 Mn |
| Sep 30, 2023 | 37.27 Mn |
| Jun 30, 2023 | 65.83 Mn |
| Mar 31, 2023 | 69,275.00 |
| Dec 31, 2022 | 75.71 Mn |
| Sep 30, 2022 | 69,150.00 |
| Jun 30, 2022 | 49.68 Mn |
| Mar 31, 2022 | 42.23 Mn |
| Dec 31, 2021 | 54.06 Mn |
| Sep 30, 2021 | 26.59 Mn |